LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: BRAZILIAN CONSENSUS ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN PEDIATRIC PATIENTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).

    Lomazi, Elizete Aparecida / Oba, Jane / Rodrigues, Maraci / Marmo, Michela Cynthia da Rocha / Sandy, Natascha Silva / Sdepanian, Vera Lucia / Imbrizi, Marcello / Baima, Júlio Pinheiro / Magro, Daniéla Oliveira / Albuquerque, Idblan Carvalho de / Zabot, Gilmara Pandolfo / Cassol, Ornella Sari / Saad-Hossne, Rogério

    Arquivos de gastroenterologia

    2023  Volume 59, Issue suppl 1, Page(s) 85–124

    Abstract: Background: Approximately 25% of patients with inflammatory bowel disease (IBD) develop the disease during childhood or adolescence and treatment aims to control active symptoms and prevent long-term complications. The management of Crohn's disease (CD) ...

    Abstract Background: Approximately 25% of patients with inflammatory bowel disease (IBD) develop the disease during childhood or adolescence and treatment aims to control active symptoms and prevent long-term complications. The management of Crohn's disease (CD) and ulcerative colitis (UC) can be especially challenging in children and adolescents, related to particularities that may affect growth, development, and puberty.
    Objective: This consensus aims to provide guidance on the most effective medical and surgical management of pediatric patients with CD or UC.
    Methods: Experts in Pediatric IBD representing Brazilian gastroenterologists (Brazilian Organization for Crohn's Disease and Colitis [GEDIIB]) developed this consensus. A rapid review was performed to support the recommendations/statements. Medical and surgical recommendations were structured and mapped according to the disease type, disease activity, and indications and contraindications for medical and surgical treatment. After structuring the statements, the modified Delphi Panel methodology was used to conduct the voting. The process took place in three rounds: two using a personalized and anonymous online voting platform and one face-to-face. Whenever participants did not agree with a specific recommendation, an option to explain why was offered to enable free-text responses and provide the opportunity for the experts to elaborate or explain disagreement. The consensus of recommendations in each round was accepted when reached ≥80% agreement.
    Results and conclusion: The recommendations are presented according to the stage of treatment and severity of the disease in three domains: management and treatment (drug and surgical interventions), criteria for evaluating the effectiveness of medical treatment, and follow-up/ patient monitoring after initial treatment, follow-up/ patient monitoring after initial treatment. Surgical recommendations were grouped according to disease type and recommended surgery. The target audience for this consensus was general practitioners, gastroenterologists, and surgeons interested in the treatment and management of pediatric CD and UC. Additionally, the consensus aimed to support the decision-making of health insurance companies, regulatory agencies, and health institutional leaders and/or administrators.
    MeSH term(s) Adolescent ; Humans ; Child ; Crohn Disease/therapy ; Crohn Disease/diagnosis ; Consensus ; Brazil ; Inflammatory Bowel Diseases/therapy ; Colitis, Ulcerative/diagnosis
    Language English
    Publishing date 2023-03-24
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 137743-7
    ISSN 1678-4219 ; 0004-2803
    ISSN (online) 1678-4219
    ISSN 0004-2803
    DOI 10.1590/S0004-2803.2022005S1-04
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: SURGICAL MANAGEMENT OF ADULT CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN'S DISEASE AND COLITIS (GEDIIB).

    Zabot, Gilmara Pandolfo / Cassol, Ornella Sari / Quaresma, Abel Botelho / Gonçalves Filho, Francisco de Assis / Baima, Júlio Pinheiro / Imbrizi, Marcello / Rolim, Alexandre de Sá / Carmo, Alexandre Medeiros do / Alves Junior, Antonio Jose Tiburcio / Santos, Carlos Henrique Marques Dos / Sobrado Junior, Carlos Walter / Miranda, Eron Fábio / Albuquerque, Idblan Carvalho de / Souza, Mardem Machado de / Kaiser Junior, Roberto Luiz / Parra, Rogerio Serafim / Kotze, Paulo Gustavo / Saad-Hossne, Rogério

    Arquivos de gastroenterologia

    2023  Volume 59, Issue suppl 1, Page(s) 1–19

    Abstract: Background: Despite optimized medical therapy, contemporary risk of surgery in inflammatory bowel diseases (IBD) after 10 years of diagnosis is 9.2% in patients with ulcerative colitis (UC) and 26.2% in Crohn's disease, (CD) in the biological era.: ... ...

    Abstract Background: Despite optimized medical therapy, contemporary risk of surgery in inflammatory bowel diseases (IBD) after 10 years of diagnosis is 9.2% in patients with ulcerative colitis (UC) and 26.2% in Crohn's disease, (CD) in the biological era.
    Objective: This consensus aims to detail guidance to the most appropriate surgical procedures in different IBD scenarios. In addition, it details surgical indications and perioperative management of adult patients with CD and UC.
    Methods: Our consensus was developed by colorectal surgeons and gastroenterologists representing the Brazilian Study Group of Inflammatory Bowel Diseases (GEDIIB), with the Rapid Review methodology being conducted to support the recommendations/statements. Surgical recommendations were structured and mapped according to the disease phenotypes, surgical indications, and techniques. After structuring the recommendations/statements, the modified Delphi Panel methodology was used to conduct the voting by experts in IBD surgery and gastroenterology. This consisted of three rounds: two using a personalized and anonymous online voting platform and one face-to-face presential meeting. Whenever participants did not agree with specific statements or recommendations, an option to outline possible reasons was offered to enable free-text responses and provide the opportunity for the experts to elaborate or explain disagreement. The consensus of recommendations/statements in each round was considered to have been reached if there was ≥80% agreement.
    Results and conclusion: This consensus addressed the most relevant information to guide the decision-making process for adequate surgical management of CD and UC. It synthesizes recommendations developed from evidence-based statements and state-of-art knowledge. Surgical recommendations were structured and mapped according to the different disease phenotypes, indications for surgery and perioperative management. Specific focus of our consensus was given to elective and emergency surgical procedures, determining when to indicate surgery and which procedures may be the more appropriate. The consensus is targeted to gastroenterologists and surgeons interested in the treatment and management of adult patients with CD or UC and supports decision-making of healthcare payors, institutional leaders, and/or administrators.
    MeSH term(s) Humans ; Colitis, Ulcerative/surgery ; Colitis, Ulcerative/diagnosis ; Crohn Disease/surgery ; Crohn Disease/diagnosis ; Consensus ; Brazil ; Inflammatory Bowel Diseases
    Language English
    Publishing date 2023-03-24
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 137743-7
    ISSN 1678-4219 ; 0004-2803
    ISSN (online) 1678-4219
    ISSN 0004-2803
    DOI 10.1590/S0004-2803.2022005S1-01
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Ulcerative colitis - treatment with biologicals.

    Teixeira, Fabio Vieira / Vilela, Eduardo Garcia / Damião, Aderson Omar Mourão Cintra / Vieira, Andrea / Albuquerque, Idblan Carvalho De / Parente, José Miguel Luz / Chebli, Júlio Maria Fonseca / Ambrogini Junior, Orlando / Hossne, Rogerio Saad / Miszputen, Sender Jankiel

    Revista da Associacao Medica Brasileira (1992)

    2019  Volume 65, Issue 4, Page(s) 547–553

    Abstract: The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this ...

    Abstract The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.
    MeSH term(s) Adalimumab/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Brazil ; Clinical Decision-Making ; Colitis, Ulcerative/drug therapy ; Cyclosporine/therapeutic use ; Humans ; Infliximab/therapeutic use ; Remission Induction ; Treatment Outcome
    Chemical Substances Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Cyclosporine (83HN0GTJ6D) ; golimumab (91X1KLU43E) ; vedolizumab (9RV78Q2002) ; Infliximab (B72HH48FLU) ; Adalimumab (FYS6T7F842)
    Language English
    Publishing date 2019-05-07
    Publishing country Brazil
    Document type Journal Article ; Practice Guideline ; Systematic Review
    ZDB-ID 2027973-5
    ISSN 1806-9282 ; 0104-4230
    ISSN (online) 1806-9282
    ISSN 0104-4230
    DOI 10.1590/1806-9282.65.4.547
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study.

    Kotze, Paulo Gustavo / Albuquerque, Idblan Carvalho de / da Luz Moreira, André / Tonini, Wanessa Bertrami / Olandoski, Marcia / Coy, Claudio Saddy Rodrigues

    Arquivos de gastroenterologia

    2014  Volume 51, Issue 4, Page(s) 284–289

    Abstract: Background: Perianal fistulizing Crohn's disease is one of the most severe phenotypes of inflammatory bowel diseases. Combined therapy with seton placement and anti-TNF therapy is the most common strategy for this condition.: Objectives: The aim of ... ...

    Abstract Background: Perianal fistulizing Crohn's disease is one of the most severe phenotypes of inflammatory bowel diseases. Combined therapy with seton placement and anti-TNF therapy is the most common strategy for this condition.
    Objectives: The aim of this study was to analyze the rates of complete perianal remission after combined therapy for perianal fistulizing Crohn's disease.
    Methods: This was a retrospective observational study with perianal fistulizing Crohn's disease patients submitted to combined therapy from four inflammatory bowel diseases referral centers. We analyzed patients' demographic characteristics, Montreal classification, concomitant medication, classification of the fistulae, occurrence of perianal complete remission and recurrence after remission. Complete perianal remission was defined as absence of drainage from the fistulae associated with seton removal.
    Discussion: A total of 78 patients were included, 44 (55.8%) females with a mean age of 33.8 (±15) years. Most patients were treated with Infliximab, 66.2%, than with Adalimumab, 33.8%. Complex fistulae were found in 52/78 patients (66.7%). After a medium follow-up of 48.2 months, 41/78 patients (52.6%) had complete perianal remission (95% CI: 43.5%-63.6%). Recurrence occurred in four (9.8%) patients (95% CI: 0.7%-18.8%) in an average period of 74.8 months.
    Conclusions: Combined therapy lead to favorable and durable results in perianal fistulizing Crohn's disease.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Inflammatory Agents/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Child ; Child, Preschool ; Combined Modality Therapy ; Crohn Disease/therapy ; Female ; Humans ; Male ; Middle Aged ; Rectal Fistula/therapy ; Recurrence ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors ; Young Adult
    Chemical Substances Anti-Inflammatory Agents ; Antibodies, Monoclonal ; Tumor Necrosis Factor-alpha
    Language English
    Publishing date 2014-10
    Publishing country Brazil
    Document type Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 137743-7
    ISSN 1678-4219 ; 0004-2803
    ISSN (online) 1678-4219
    ISSN 0004-2803
    DOI 10.1590/S0004-28032014000400004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top